WANBURYNSEWanbury Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 26 Mar · 16:32 IST

Wanbury Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.1%1-day move
₹233.50
prior close
₹240.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.8-2.6-1.6-1.7-4.1-1.3-0.7-2.6-3.7+0.6+15.6+11.3+28.6+21.6
Up moveDown movePending
AI summary

Wanbury Limited has informed the stock exchanges that the trading window for dealing in its securities will remain closed for designated persons, including directors, key managerial personnel, identified employees, promoters, promoter group members, their immediate relatives, and connected persons. The window closure begins from 1st April, 2026 and will continue until 48 hours after the declaration of the Audited Financial Results for the quarter and financial year ended 31st March, 2026. The date of the board meeting to approve these results will be communicated separately in due course. This is a standard regulatory compliance filing ahead of the upcoming annual earnings announcement.

Likely market impact

No direct impact on shareholders or stock price. This is a routine compliance measure that signals audited FY26 financial results are upcoming, which investors should watch for as the next material catalyst.